Immunitybio Inc

NASDAQ IBRX

Data sourced from iex and EODHD
Download Data

Immunitybio Inc Balance Sheet 2013 - 2023

This table shows the Balance Sheet for Immunitybio Inc going from 2013 until 2023. The balance sheet is a financial statement that presents the financial position of a company at a specific point in time, typically at the end of a fiscal period. It consists of three main components: assets (such as cash, inventory, property, and investments), liabilities (including debts, loans, and obligations), and shareholders' equity (the residual interest in the company's assets after deducting liabilities). The balance sheet provides insights into a company's liquidity, solvency, and overall financial health.
Balance Sheet Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31
Cash
M 265 105 181 35 16 17 24 8 176 59 0
Short-Term Investments
M 1 3 136 61 36 57 104 191 118 - -
Cash and Short-Term Investments
M 266 107 317 96 52 74 128 199 294 59 0
Receivables
M 3 2 1 2 0 12 1 3 2 0 0
Inventory
M - 26 - - - - - - - - -
Other Current Assets
M 24 5 16 14 4 2 3 4 2 0 0
Current Assets
M 294 141 334 112 56 89 132 205 298 59 1
Property, Plant, Equipment (Net)
M 183 189 119 91 72 77 77 19 6 0 0
Goodwill
M - - - - - - - - - - -
Intangible Assets
M 17 20 1 1 12 1 3 5 7 1 1
Goodwill and Intangible Assets
M - - - - - - - - - - -
Tangible Assets
M - -467 -244 -237 -119 -63 - - - - -
Long-Term Investments
M 1 1 1 11 - - - - - - -
Total Investments
M 2 3 137 73 - - - - - - -
Long-Term Assets (Other)
M 2 7 7 3 -11 16 38 88 56 0 0
Total Long-Term Assets
M 210 222 135 110 87 93 118 112 69 1 1
Total Assets
M 504 362 469 221 143 182 250 317 367 61 2
Accounts Payable
M 9 21 11 12 2 3 6 4 2 1 2
Short-Term Debt
M 7 435 302 5 4 - 0 0 0 0 2
Current Revenue (Deferred)
M 0 0 - - - - 0 0 0 1 1
Other Current Liabilities
M 42 45 55 52 6 24 15 9 4 0 1
Current Liabilities
M 58 501 369 68 12 27 21 13 6 2 5
Long-Term Debt
M 682 241 306 254 - - - - - - -
Non-Current Liabilities (Other)
M 157 70 344 10 - - - - - - -
Total Non-Current Liabilities
M 1,032 311 344 272 11 9 11 12 5 2 4
Total Liabilities
M 1,090 812 713 340 22 36 32 24 11 2 5
Additional Paid-in Capital
M - 1,931 1,720 1,495 783 741 718 681 - - -
Common Stock (Net)
M - 0 0 0 0 0 0 0 0 0 0
Retained Earnings
M - -2,378 -1,962 -755 - - - - - - -
Accumulated Other Comprehensive Income
M 0 0 0 0 0 -12 -4 -1 0 0 0
Capital Lease Obligations
M 45 51 40 21 - - - - - - -
Shareholders' Equity
M -587 -447 -242 -120 121 146 219 293 356 58 -3
Shareholders' Equity and Liabilities
M 504 362 469 221 143 182 250 317 367 61 2
Treasury Stock
M - - - - - - - - - - -
Shares (Common, Diluted)
M 509 400 389 383 383 79 81 82 72 79 -
Shareholders' Equity (Tangible)
M - -467 -244 -236 - - - - - - -
Net Debt
M - - - - - - - - - - -
Total Debt
M 688 676 609 259 - - - - - - -
Current Part of Long-Term Debt
M - 432 299 - - - - - - - -

StockViz Staff

September 20, 2024

Any question? Send us an email